問卷

TPIDB > Search Result

Search Result

篩選

List

5239Cases

2014-10-01 - 2016-10-30

Phase II/III

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2015-01-01 - 2016-07-31

Others

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2019-06-01 - 2021-06-11

Phase II

Multinational, Multicenter, Phase 2 Study of Tesetaxel Plus a Reduced Dose of Capecitabine in Patients With HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received a Taxane
  • Condition/Disease

    HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer

  • Test Drug

    Tesetaxel

Participate Sites
4Sites

Terminated4Sites

2018-11-01 - 2019-10-31

Phase III

A prospective, randomized, evaluator blind, active-controlled, parallel study of the efficacy and safety of Quiklean® and Klean-Prep with Dulcolax® for the bowel preparation prior to colonoscopy
  • Condition/Disease

    bowel preparation in subjects undergoing colonoscopy

  • Test Drug

    Quiklean

Participate Sites
2Sites

Terminated1Sites

Study ended1Sites

陳自諒
China Medical University Hospital

Division of Colorectal Surgery

2007-07-01 - 2009-06-30

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2007-05-01 - 2009-04-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Terminated9Sites

2008-12-01 - 2011-11-30

Phase III

A randomised, double-blind, parallel-group placebo-controlled phase Ill study to evaluate the efficacy and safety of desmoteplase in subjects with acute ischemic stroke
  • Condition/Disease

    Ischemic stroke

  • Test Drug

    Desmoteplase

Participate Sites
6Sites

Terminated6Sites

2009-03-01 - 2010-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2009-03-01 - 2010-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2007-06-01 - 2009-02-28

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites